RHY.AX ASX
Rhythm Biosciences Limited
1W: -2.4%
1M: -5.9%
3M: -14.0%
YTD: -64.4%
1Y: -12.1%
3Y: -78.2%
5Y: -91.8%
A$0.08 ($0.05)
-0.00 (-1.25%)
Weekly Expected Move ±5.1%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$5M
-79.1% ▼
Capital Expenditures
$26K
-11.1% ▼
5Y CAGR: -17.7%
Free Cash Flow
-$5M
-78.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+184.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$8M | -$7M | -$4M | -$6M |
| Depreciation & Amort. | $101K | $189K | $199K | $197K | $189K |
| Stock-Based Comp. | $3M | $3M | $0 | $349K | $0 |
| Change in Working Capital | -$410K | -$2M | $2M | $362K | $31K |
| Other Non-Cash Items | $410K | $3M | -$1M | -$90 | $477K |
| Operating Cash Flow | -$6M | -$7M | -$6M | -$3M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$27K | -$99K | -$82K | -$23K | -$26K |
| Acquisitions (Net) | $0 | $0 | $0 | -$520K | $3K |
| Investment Purchases | $0 | $0 | $0 | -$40K | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$27K | -$99K | -$82K | -$583K | -$23K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$8K | -$86K | -$93K | -$89K | -$1M |
| Stock Repurchased | -$468K | -$24K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $1M | -$107K |
| Financing Cash Flow | $12M | $4M | $3M | $4M | $7M |
| Net Change in Cash | $5M | -$3M | -$3M | $688K | $2M |
| Cash End of Period | $8M | $4M | $709K | $1M | $3M |
| Free Cash Flow | -$6M | -$7M | -$6M | -$3M | -$5M |